US EditionTrump signs executive order slashing prescription drug costs by up to 80%
- President Donald Trump announced on Sunday that he will sign an executive order Monday to reduce U.S. Prescription drug prices at the White House.
- This order revives a failed first-term effort to tie Medicare Part B drug prices to the lowest prices paid by other developed countries.
- The plan likely affects certain expensive drugs administered in doctors' offices, such as cancer infusions and injectables, but not common pharmacy drugs.
- Trump claimed the policy, called 'most favored nation,' will save 'trillions of dollars' and reduce healthcare costs significantly, though this may be exaggerated.
- The proposal faces strong pharmaceutical industry opposition, which argues lower prices could reduce profits and hinder drug innovation.
447 Articles
447 Articles
Trump signs order aiming to lower U.S. drug costs to match prices abroad
A pharmacy manager retrieves a bottle of antibiotics. (Photo by Joe Raedle/Getty Images)WASHINGTON — President Donald Trump signed an executive order Monday aimed at lowering drug prices by pressuring pharmaceutical companies to align their U.S. pricing models with those in similarly wealthy countries. “We’ll slash the cost of prescription drugs and will bring fairness to America,” Trump said at a morning White House event. “We’re all gonna pay …
Trump says he'll set 30-day deadline for drugmakers to lower the cost of prescription drugs
President Donald Trump says he’ll set a 30-day deadline for drugmakers to lower the cost of prescription drugs in a sweeping executive order that he will sign. Drugmakers argue threats to their profits could impact research to develop new drugs.
Coverage Details
Bias Distribution
- 52% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
